Pietro Mesirca Selected Research

tertiapin

1/2020

Inhibition of G protein-gated K+ channels by tertiapin-Q rescues sinus node dysfunction and atrioventricular conduction in mouse models of primary bradycardia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Mesirca Research Topics

Disease

2	Heart Block 01/2020 - 02/2016
2	Sick Sinus Syndrome 01/2020 - 02/2016
2	Bradycardia 01/2020 - 01/2020
1	Inflammation (Inflammations) 11/2021
1	Atrial Fibrillation 07/2013
1	Heart Failure 07/2013
1	Cardiomegaly (Heart Hypertrophy) 07/2013
1	Polymorphic catecholergic ventricular tachycardia 07/2012

Drug/Important Bio-Agent (IBA)

3	GTP-Binding Proteins (G-Protein)IBA 01/2020 - 02/2016
2	MicroRNAs (MicroRNA)IBA 11/2021 - 01/2020
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	tertiapinIBA 01/2020
1	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 01/2020
1	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 01/2020
1	Cholinergic Agents (Cholinergics)IBA 02/2016
1	Trinitrotoluene (TNT)IBA 07/2013
1	Phosphotransferases (Kinase)IBA 07/2013
1	TRPC6 Cation ChannelIBA 07/2013
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 07/2012
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 07/2012

Therapy/Procedure

1	Therapeutics 01/2020